Skip to main content
Erschienen in: Osteoporosis International 12/2005

01.12.2005 | Original Article

Lumbar bone mineral density in very long-term renal transplant recipients: Impact of circulating sex hormones

verfasst von: Vincent M. Brandenburg, Markus Ketteler, Nicole Heussen, Dirk Politt, Rolf D. Frank, Ralf Westenfeld, Thomas H. Ittel, Jürgen Floege

Erschienen in: Osteoporosis International | Ausgabe 12/2005

Einloggen, um Zugang zu erhalten

Abstract

The influence of circulating sex hormones and gender on the bone mineral density (BMD) in long-term renal transplant recipients needs further investigation. We performed a retrospective analysis of lumbar BMD between 6 years and 20 years after renal transplantation. In 67 patients (47±12 years, 38 male) with a minimum interval of 72 months after transplantation, lumbar BMD measurements (dual energy X-ray absorptiometry) were performed (=complete cohort). Thirty-one patients (=longitudinal cohort) underwent at least three serial BMD measurements (mean follow-up 39±18 months, start at 86±22 months). All patients received prednisolone. In the complete cohort, BMD was significantly reduced in comparison to young healthy (mean T -score −1.33±1.40) and age-matched controls (mean Z -score −0.91±1.45) at 88±31 months ( p <0.05). Osteopenia or osteoporosis were present in two-thirds of patients. In the longitudinal cohort, a mean annual lumbar BMD loss of −0.6±1.9% was detectable equivalent to a −0.03±0.15 reduction of Z -scores per year (regression analysis). Impact of hormonal status: In the complete cohort, postmenopausal status was associated with significantly lower BMD levels compared to men ( p =0.0441). Women and men within the lowest tertile of sex hormone levels (LH, FSH, DHEAS, testosterone, progesterone, estradiol) did not exhibit significant differences in terms of lumbar BMD compared to those in the highest tertile. The mean annual bone loss was statistically indistinguishable between men and women. There was no significant correlation of sex hormone levels and BMD in men and premenopausal women. In postmenopausal women, however, low estradiol and high LH levels correlated with the extent of annual BMD loss ( p <0.05). Our data confirm significantly reduced lumbar T -scores in the very late period after renal transplantation. The lumbar BMD decreased by −0.6±1.9% per year. In postmenopausal long-term renal transplant recipients, low estradiol levels were associated with accelerated bone loss.
Literatur
1.
Zurück zum Zitat Julian BA, Laskow DA, Dubovsky J, Dubovsky EV, Curtis JJ, Quarles LD (1991) Rapid loss of vertebral mineral density after renal transplantation. N Engl J Med 325:544–550PubMed Julian BA, Laskow DA, Dubovsky J, Dubovsky EV, Curtis JJ, Quarles LD (1991) Rapid loss of vertebral mineral density after renal transplantation. N Engl J Med 325:544–550PubMed
2.
Zurück zum Zitat Grotz W, Mundinger A, Gugel B, Exner V, Reichelt A, Schollmeyer P (1994) Missing impact of cyclosporine on osteoporosis in renal transplant recipients. Transplant Proc 26:2652–2653PubMed Grotz W, Mundinger A, Gugel B, Exner V, Reichelt A, Schollmeyer P (1994) Missing impact of cyclosporine on osteoporosis in renal transplant recipients. Transplant Proc 26:2652–2653PubMed
3.
Zurück zum Zitat Kim H, Chang K, Lee T, Kwon J, Park S (1998) Bone mineral density after renal transplantation. Transplant Proc 30:3029–3030CrossRefPubMed Kim H, Chang K, Lee T, Kwon J, Park S (1998) Bone mineral density after renal transplantation. Transplant Proc 30:3029–3030CrossRefPubMed
4.
Zurück zum Zitat Vautour LM, Melton LJ 3rd, Clarke BL, Achenbach SJ, Oberg AL, McCarthy JT (2003) Long-term fracture risk following renal transplantation: a population-based study. Osteoporos Int:160–167 Vautour LM, Melton LJ 3rd, Clarke BL, Achenbach SJ, Oberg AL, McCarthy JT (2003) Long-term fracture risk following renal transplantation: a population-based study. Osteoporos Int:160–167
5.
Zurück zum Zitat Ramsey-Goldman R, Dunn JE, Dunlop DD, Stuart FP, Abecassis MM, Kaufman DB, Langman CB, Salinger MH, Sprague SM (1999) Increased risk of fracture in patients receiving solid organ transplants. J Bone Miner Res 14:456–463PubMed Ramsey-Goldman R, Dunn JE, Dunlop DD, Stuart FP, Abecassis MM, Kaufman DB, Langman CB, Salinger MH, Sprague SM (1999) Increased risk of fracture in patients receiving solid organ transplants. J Bone Miner Res 14:456–463PubMed
6.
Zurück zum Zitat Taal MW, Roe S, Masud T, Green D, Porter C, Cassidy MJ (2003) Total hip bone mass predicts survival in chronic hemodialysis patients. Kidney Int 63:1116–1120CrossRefPubMed Taal MW, Roe S, Masud T, Green D, Porter C, Cassidy MJ (2003) Total hip bone mass predicts survival in chronic hemodialysis patients. Kidney Int 63:1116–1120CrossRefPubMed
7.
Zurück zum Zitat Grotz WH, Mundinger FA, Rasenack J, Speidel L, Olschewski M, Exner VM, Schollmeyer PJ (1995) Bone loss after kidney transplantation: a longitudinal study in 115 graft recipients. Nephrol Dial Transplant 10:2096–2100PubMed Grotz WH, Mundinger FA, Rasenack J, Speidel L, Olschewski M, Exner VM, Schollmeyer PJ (1995) Bone loss after kidney transplantation: a longitudinal study in 115 graft recipients. Nephrol Dial Transplant 10:2096–2100PubMed
8.
Zurück zum Zitat Brandenburg VM, Westenfeld R, Ketteler M (2004) The fate of bone after renal transplantation. J Nephrol 17:190–204CrossRefPubMed Brandenburg VM, Westenfeld R, Ketteler M (2004) The fate of bone after renal transplantation. J Nephrol 17:190–204CrossRefPubMed
9.
Zurück zum Zitat Mikuls TR, Julian BA, Bartolucci A, Saag KG (2003) Bone mineral density changes within 6 months of renal transplantation. Transplantation 75:49–54CrossRefPubMed Mikuls TR, Julian BA, Bartolucci A, Saag KG (2003) Bone mineral density changes within 6 months of renal transplantation. Transplantation 75:49–54CrossRefPubMed
10.
Zurück zum Zitat Lippuner K, Casez JP, Horber FF, Jaeger P (1998) Effects of deflazacort versus prednisone on bone mass, body composition, and lipid profile: a randomized, double blind study in kidney transplant patients. J Clin Endocrinol Metab 83:3795–3802CrossRefPubMed Lippuner K, Casez JP, Horber FF, Jaeger P (1998) Effects of deflazacort versus prednisone on bone mass, body composition, and lipid profile: a randomized, double blind study in kidney transplant patients. J Clin Endocrinol Metab 83:3795–3802CrossRefPubMed
11.
Zurück zum Zitat Brandenburg VM, Politt D, Ketteler M, Fassbender WJ, Heussen N, Westenfeld R, Freuding T, Floege J, Ittel TH (2004) Early rapid loss followed by long-term consolidation characterizes the development of lumbar bone mineral density after kidney transplantation. Transplantation 77:1566–1571CrossRefPubMed Brandenburg VM, Politt D, Ketteler M, Fassbender WJ, Heussen N, Westenfeld R, Freuding T, Floege J, Ittel TH (2004) Early rapid loss followed by long-term consolidation characterizes the development of lumbar bone mineral density after kidney transplantation. Transplantation 77:1566–1571CrossRefPubMed
12.
Zurück zum Zitat Nam JH, Moon JI, Chung SS, Kim SI, Park KI, Song YD, Kim KR, Lee HC, Huh K, Lim SK (2000) Pamidronate and calcitriol trial for the prevention of early bone loss after renal transplantation. Transplant Proc 32:1876CrossRefPubMed Nam JH, Moon JI, Chung SS, Kim SI, Park KI, Song YD, Kim KR, Lee HC, Huh K, Lim SK (2000) Pamidronate and calcitriol trial for the prevention of early bone loss after renal transplantation. Transplant Proc 32:1876CrossRefPubMed
13.
Zurück zum Zitat Ugur A, Guvener N, Isiklar I, Karakayali H, Erdal R (2000) Efficiency of preventive treatment for osteoporosis after renal transplantation. Transplant Proc 32:556–557CrossRefPubMed Ugur A, Guvener N, Isiklar I, Karakayali H, Erdal R (2000) Efficiency of preventive treatment for osteoporosis after renal transplantation. Transplant Proc 32:556–557CrossRefPubMed
14.
Zurück zum Zitat Feber J, Cochat P, Braillon P, Castelo F, Martin X, Glastre C, Chapuis F, David L, Meunier PJ (1994) Bone mineral density after renal transplantation in children. J Pediatr 125:870–875PubMed Feber J, Cochat P, Braillon P, Castelo F, Martin X, Glastre C, Chapuis F, David L, Meunier PJ (1994) Bone mineral density after renal transplantation in children. J Pediatr 125:870–875PubMed
15.
Zurück zum Zitat Brandenburg VM, Ketteler M, Fassbender WJ, Heussen N, Freuding T, Floege J, Ittel TH (2002) Development of lumbar bone mineral density in the late course after kidney transplantation. Am J Kidney Dis 40:1066–1074CrossRefPubMed Brandenburg VM, Ketteler M, Fassbender WJ, Heussen N, Freuding T, Floege J, Ittel TH (2002) Development of lumbar bone mineral density in the late course after kidney transplantation. Am J Kidney Dis 40:1066–1074CrossRefPubMed
16.
Zurück zum Zitat Grotz WH, Rump LC, Niessen A, Schmidt-Gayk H, Reichelt A, Kirste G, Olschewski M, Schollmeyer PJ (1998) Treatment of osteopenia and osteoporosis after kidney transplantation. Transplantation 66:1004–1008CrossRefPubMed Grotz WH, Rump LC, Niessen A, Schmidt-Gayk H, Reichelt A, Kirste G, Olschewski M, Schollmeyer PJ (1998) Treatment of osteopenia and osteoporosis after kidney transplantation. Transplantation 66:1004–1008CrossRefPubMed
17.
Zurück zum Zitat Pichette V, Bonnardeaux A, Prudhomme L, Gagne M, Cardinal J, Ouimet D (1996) Long-term bone loss in kidney transplant recipients: a cross-sectional and longitudinal study. Am J Kidney Dis 28:105–114PubMed Pichette V, Bonnardeaux A, Prudhomme L, Gagne M, Cardinal J, Ouimet D (1996) Long-term bone loss in kidney transplant recipients: a cross-sectional and longitudinal study. Am J Kidney Dis 28:105–114PubMed
18.
Zurück zum Zitat Cruz DN, Wysolmerski JJ, Brickel HM, Gundberg CG, Simpson CA, Mitnick MA, Kliger AS, Lorber MI, Basadonna GP, Friedman AL, Insogna KL, Bia MJ (2001) Parameters of high bone-turnover predict bone loss in renal transplant patients: a longitudinal study. Transplantation 72:83–88CrossRefPubMed Cruz DN, Wysolmerski JJ, Brickel HM, Gundberg CG, Simpson CA, Mitnick MA, Kliger AS, Lorber MI, Basadonna GP, Friedman AL, Insogna KL, Bia MJ (2001) Parameters of high bone-turnover predict bone loss in renal transplant patients: a longitudinal study. Transplantation 72:83–88CrossRefPubMed
19.
Zurück zum Zitat Cummings SR, Browner WS, Bauer D, Stone K, Ensrud K, Jamal S, Ettinger B (1998) Endogenous hormones and the risk of hip and vertebral fractures among older women. Study of Osteoporotic Fractures Research Group. N Engl J Med 339:733–738CrossRefPubMed Cummings SR, Browner WS, Bauer D, Stone K, Ensrud K, Jamal S, Ettinger B (1998) Endogenous hormones and the risk of hip and vertebral fractures among older women. Study of Osteoporotic Fractures Research Group. N Engl J Med 339:733–738CrossRefPubMed
20.
Zurück zum Zitat Roe SD, Porter CJ, Godber IM, Hosking DJ, Cassidy MJ (2005) Reduced bone mineral density in male renal transplant recipients: evidence for persisting hyperparathyroidism. Osteoporos Int 16(2):142–148 [epub, 2004]CrossRefPubMed Roe SD, Porter CJ, Godber IM, Hosking DJ, Cassidy MJ (2005) Reduced bone mineral density in male renal transplant recipients: evidence for persisting hyperparathyroidism. Osteoporos Int 16(2):142–148 [epub, 2004]CrossRefPubMed
21.
Zurück zum Zitat Devogelaer JP, Broll H, Correa-Rotter R, Cumming DC, De Deuxchaisnes CN, Geusens P, Hosking D, Jaeger P, Kaufman JM, Leite M, Leon J, Liberman U, Menkes CJ, Meunier PJ, Reid I, Rodriguez J, Romanowicz A, Seeman E, Vermeulen A, Hirsch LJ, Lombardi A, Plezia K, Santora AC, Yates AJ, Yuan W (1996) Oral alendronate induces progressive increases in bone mass of the spine, hip, and total body over 3 years in postmenopausal women with osteoporosis. Bone 18:141–150CrossRefPubMed Devogelaer JP, Broll H, Correa-Rotter R, Cumming DC, De Deuxchaisnes CN, Geusens P, Hosking D, Jaeger P, Kaufman JM, Leite M, Leon J, Liberman U, Menkes CJ, Meunier PJ, Reid I, Rodriguez J, Romanowicz A, Seeman E, Vermeulen A, Hirsch LJ, Lombardi A, Plezia K, Santora AC, Yates AJ, Yuan W (1996) Oral alendronate induces progressive increases in bone mass of the spine, hip, and total body over 3 years in postmenopausal women with osteoporosis. Bone 18:141–150CrossRefPubMed
22.
Zurück zum Zitat Tucci JR, Tonino RP, Emkey RD, Peverly CA, Kher U, Santora AC (1996) Effect of three years of oral alendronate treatment in postmenopausal women with osteoporosis. Am J Med 101:488–501CrossRefPubMed Tucci JR, Tonino RP, Emkey RD, Peverly CA, Kher U, Santora AC (1996) Effect of three years of oral alendronate treatment in postmenopausal women with osteoporosis. Am J Med 101:488–501CrossRefPubMed
23.
Zurück zum Zitat Liberman UA, Weiss SR, Broll J, Minne HW, Quan H, Bell NH, Rodriguez-Portales J, Downs RW Jr, Dequeker J, Favus M (1995) Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis. The Alendronate Phase III Osteoporosis Treatment Study Group. N Engl J Med 333:1437–1443CrossRefPubMed Liberman UA, Weiss SR, Broll J, Minne HW, Quan H, Bell NH, Rodriguez-Portales J, Downs RW Jr, Dequeker J, Favus M (1995) Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis. The Alendronate Phase III Osteoporosis Treatment Study Group. N Engl J Med 333:1437–1443CrossRefPubMed
24.
Zurück zum Zitat Montalban C, De Francisco AL, Marinoso ML, Zubimendi JA, Unzueta MG, Amado JA, Arias M (2003) Bone disease in long-term adult kidney transplant patients with normal renal function. Kidney Int [Suppl] 129–132 Montalban C, De Francisco AL, Marinoso ML, Zubimendi JA, Unzueta MG, Amado JA, Arias M (2003) Bone disease in long-term adult kidney transplant patients with normal renal function. Kidney Int [Suppl] 129–132
25.
Zurück zum Zitat Saag KG, Emkey R, Schnitzer TJ, Brown JP, Hawkins F, Goemaere S, Thamsborg G, Liberman UA, Delmas PD, Malice MP, Czachur M, Daifotis AG (1998) Alendronate for the prevention and treatment of glucocorticoid-induced osteoporosis. Glucocorticoid-Induced Osteoporosis Intervention Study Group. N Engl J Med 339:292–299CrossRefPubMed Saag KG, Emkey R, Schnitzer TJ, Brown JP, Hawkins F, Goemaere S, Thamsborg G, Liberman UA, Delmas PD, Malice MP, Czachur M, Daifotis AG (1998) Alendronate for the prevention and treatment of glucocorticoid-induced osteoporosis. Glucocorticoid-Induced Osteoporosis Intervention Study Group. N Engl J Med 339:292–299CrossRefPubMed
26.
Zurück zum Zitat Cueto-Manzano AM, Konel S, Hutchison AJ, Crowley V, France MW, Freemont AJ, Adams JE, Mawer B, Gokal R (1999) Bone loss in long-term renal transplantation: histopathology and densitometry analysis. Kidney Int 55:2021–2029CrossRefPubMed Cueto-Manzano AM, Konel S, Hutchison AJ, Crowley V, France MW, Freemont AJ, Adams JE, Mawer B, Gokal R (1999) Bone loss in long-term renal transplantation: histopathology and densitometry analysis. Kidney Int 55:2021–2029CrossRefPubMed
27.
Zurück zum Zitat Horber FF, Casez JP, Steiger U, Czerniak A, Montandon A, Jaeger P (1994) Changes in bone mass early after kidney transplantation. J Bone Miner Res 9:1–9PubMed Horber FF, Casez JP, Steiger U, Czerniak A, Montandon A, Jaeger P (1994) Changes in bone mass early after kidney transplantation. J Bone Miner Res 9:1–9PubMed
28.
Zurück zum Zitat Almond MK, Kwan JT, Evans K, Cunningham J (1994) Loss of regional bone mineral density in the first 12 months following renal transplantation. Nephron 66:52–57PubMed Almond MK, Kwan JT, Evans K, Cunningham J (1994) Loss of regional bone mineral density in the first 12 months following renal transplantation. Nephron 66:52–57PubMed
29.
Zurück zum Zitat Wolpaw T, Deal CL, Fleming-Brooks S, Bartucci MR, Schulak JA, Hricik DE (1994) Factors influencing vertebral bone density after renal transplantation. Transplantation 58:1186–1189PubMed Wolpaw T, Deal CL, Fleming-Brooks S, Bartucci MR, Schulak JA, Hricik DE (1994) Factors influencing vertebral bone density after renal transplantation. Transplantation 58:1186–1189PubMed
30.
Zurück zum Zitat Patel S, Kwan JT, McCloskey E, McGee G, Thomas G, Johnson D, Wills R, Ogunremi L, Barron J (2001) Prevalence and causes of low bone density and fractures in kidney transplant patients. J Bone Miner Res 16:1863–1870PubMed Patel S, Kwan JT, McCloskey E, McGee G, Thomas G, Johnson D, Wills R, Ogunremi L, Barron J (2001) Prevalence and causes of low bone density and fractures in kidney transplant patients. J Bone Miner Res 16:1863–1870PubMed
31.
Zurück zum Zitat Cueto-Manzano AM, Freemont AJ, Adams JE, Mawer B, Gokal R, Hutchison AJ (2001) Association of sex hormone status with the bone loss of renal transplant patients. Nephrol Dial Transplant 16:1245–1250CrossRefPubMed Cueto-Manzano AM, Freemont AJ, Adams JE, Mawer B, Gokal R, Hutchison AJ (2001) Association of sex hormone status with the bone loss of renal transplant patients. Nephrol Dial Transplant 16:1245–1250CrossRefPubMed
32.
Zurück zum Zitat Leavey SF, Weitzel WF (2002) Endocrine abnormalities in chronic renal failure. Endocrinol Metab Clin North Am 31:107–119CrossRefPubMed Leavey SF, Weitzel WF (2002) Endocrine abnormalities in chronic renal failure. Endocrinol Metab Clin North Am 31:107–119CrossRefPubMed
33.
Zurück zum Zitat Tauchmanova L, Carrano R, Sabbatini M, De Rosa M, Orio F, Palomba S, Cascella T, Lombardi G, Federico S, Colao A (2004) Hypothalamic-pituitary-gonadal axis function after successful kidney transplantation in men and women. Hum Reprod 19:867–873CrossRefPubMed Tauchmanova L, Carrano R, Sabbatini M, De Rosa M, Orio F, Palomba S, Cascella T, Lombardi G, Federico S, Colao A (2004) Hypothalamic-pituitary-gonadal axis function after successful kidney transplantation in men and women. Hum Reprod 19:867–873CrossRefPubMed
34.
Zurück zum Zitat (2002) European best practice guidelines for renal transplantation. Section IV: Long-term management of the transplant recipient. IV.8. Bone disease. Nephrol Dial Transplant 17 [Suppl 4]:43–48 (2002) European best practice guidelines for renal transplantation. Section IV: Long-term management of the transplant recipient. IV.8. Bone disease. Nephrol Dial Transplant 17 [Suppl 4]:43–48
35.
Zurück zum Zitat Warren MP (2004) A comparative review of the risks and benefits of hormone replacement therapy regimens. Am J Obstet Gynecol 190:1141–1167CrossRefPubMed Warren MP (2004) A comparative review of the risks and benefits of hormone replacement therapy regimens. Am J Obstet Gynecol 190:1141–1167CrossRefPubMed
36.
Zurück zum Zitat Hernandez E, Valera R, Alonzo E, Bajares-Lilue M, Carlini R, Capriles F, Martinis R, Bellorin-Font E, Weisinger JR (2003) Effects of raloxifene on bone metabolism and serum lipids in postmenopausal women on chronic hemodialysis. Kidney Int 63:2269–2274CrossRefPubMed Hernandez E, Valera R, Alonzo E, Bajares-Lilue M, Carlini R, Capriles F, Martinis R, Bellorin-Font E, Weisinger JR (2003) Effects of raloxifene on bone metabolism and serum lipids in postmenopausal women on chronic hemodialysis. Kidney Int 63:2269–2274CrossRefPubMed
Metadaten
Titel
Lumbar bone mineral density in very long-term renal transplant recipients: Impact of circulating sex hormones
verfasst von
Vincent M. Brandenburg
Markus Ketteler
Nicole Heussen
Dirk Politt
Rolf D. Frank
Ralf Westenfeld
Thomas H. Ittel
Jürgen Floege
Publikationsdatum
01.12.2005
Verlag
Springer-Verlag
Erschienen in
Osteoporosis International / Ausgabe 12/2005
Print ISSN: 0937-941X
Elektronische ISSN: 1433-2965
DOI
https://doi.org/10.1007/s00198-005-1884-6

Weitere Artikel der Ausgabe 12/2005

Osteoporosis International 12/2005 Zur Ausgabe

Arthropedia

Grundlagenwissen der Arthroskopie und Gelenkchirurgie. Erweitert durch Fallbeispiele, Videos und Abbildungen. 
» Jetzt entdecken

Update Orthopädie und Unfallchirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.